Natera, Inc.’s $103 Million Follow-on Public Offering

Gunderson Dettmer advised Natera, Inc. in a follow-on public offering of 5,175,000 shares at the price to the public of $20.00 per share for a total of $103,500,000 in aggregate gross proceeds.

The underwriting syndicate included J.P. Morgan, Morgan Stanley and Cowen.

Natera, which trades on the Nasdaq under the ticker symbol “NTRA,” is a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA. The company, led by Matthew Rabinowitz,

Steve Chapman and Jonathan Sheena in 2017 recoreded $210 Million Revenues.

Gunderson Dettmer advised Natera with a team including Richard Blake (Picture), Heidi Mayon, John Dietz, Owais Mahesri and Cathy Kwon.

Involved fees earner: Richard Blake – Gunderson Dettmer; Heidi Mayon – Gunderson Dettmer; John Dietz – Gunderson Dettmer; Owais Mahesri – Gunderson Dettmer; Cathy Kwon – Gunderson Dettmer;

Law Firms: Gunderson Dettmer;

Clients: Natera, Inc.;

Author: Ambrogio Visconti